Harvey M. Golomb to Antineoplastic Agents
This is a "connection" page, showing publications Harvey M. Golomb has written about Antineoplastic Agents.
Connection Strength
0.680
-
Hairy cell leukemia: treatment successes in the past 25 years. J Clin Oncol. 2008 Jun 01; 26(16):2607-9.
Score: 0.144
-
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer. Ann Oncol. 1998 Oct; 9(10):1085-90.
Score: 0.074
-
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
Score: 0.062
-
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
Score: 0.059
-
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Semin Oncol. 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4.
Score: 0.056
-
What is the choice of treatment for hairy cell leukemia? J Clin Oncol. 1989 Feb; 7(2):156-8.
Score: 0.038
-
Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma. Am J Hematol. 1988 Jan; 27(1):60-2.
Score: 0.035
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.025
-
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.
Score: 0.022
-
The treatment of histiocytic lymphoma. Semin Oncol. 1980 Sep; 7(3):302-9.
Score: 0.021
-
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
Score: 0.019
-
Management of early-stage Hodgkin's disease: a continuing evolution. Semin Oncol. 1998 Aug; 25(4):476-82.
Score: 0.018
-
The treatment of hairy cell leukemia: an update. Leukemia. 1992; 6 Suppl 2:24-7.
Score: 0.012
-
Design of combination biotherapy studies: future goals and challenges. Semin Oncol. 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41.
Score: 0.010
-
Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.
Score: 0.007
-
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
Score: 0.006
-
Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8.
Score: 0.006
-
VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
Score: 0.006
-
Treatment of stage IIIA Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):827-34.
Score: 0.006
-
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
Score: 0.005
-
Non-Hodgkin lymphoma. Introduction. Semin Oncol. 1980 Sep; 7(3):221-2.
Score: 0.005
-
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med. 1980 Jun; 92(6):785-90.
Score: 0.005
-
Importance of substaging of stage III Hodgkin's disease. Semin Oncol. 1980 Jun; 7(2):136-43.
Score: 0.005
-
Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
Score: 0.005
-
Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug; 42(2 Suppl):946-56.
Score: 0.005
-
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
Score: 0.005
-
Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978 Apr; 41(4):1374-80.
Score: 0.004
-
Letter: Chemotherapy of advanced histocytic lymphomas. Lancet. 1975 May 17; 1(7916):1136.
Score: 0.004
-
The non-Hodgkin's lymphomas: a review. Rev Bras Pesqui Med Biol. 1974 Mar-Apr; 7(2):123-31.
Score: 0.003
-
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
Score: 0.002
-
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
Score: 0.002
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
Score: 0.002
-
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
Score: 0.001
-
Lymphoblastic lymphoma in adults. Cancer. 1981 May 15; 47(10):2510-6.
Score: 0.001
-
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer. 1981 Feb 15; 47(4):748-56.
Score: 0.001